Published in Lancet on August 18, 2010
Delayed graft function in the kidney transplant. Am J Transplant (2011) 2.06
Standardized deceased donor kidney donation rates in the UK reveal marked regional variation and highlight the potential for increasing kidney donation: a prospective cohort study†. Br J Anaesth (2013) 1.43
Kidney donation after circulatory death (DCD): state of the art. Kidney Int (2015) 0.95
The predictive value of kidney allograft baseline biopsies for long-term graft survival. J Am Soc Nephrol (2013) 0.89
The effect of prolonged of warm ischaemic injury on renal function in an experimental ex vivo normothermic perfusion system. J Transl Med (2015) 0.89
Organ transplantation after cardiac death. Lancet (2011) 0.81
Late graft loss among pediatric recipients of DCD kidneys. Clin J Am Soc Nephrol (2011) 0.78
Transplantation: Prolonged cold ischaemic time reduces graft survival in kidneys from controlled-circulatory-death donors. Nat Rev Nephrol (2013) 0.75
Organ transplantation after cardiac death. Lancet (2011) 0.75
Optimizing Graft Survival by Pretreatment of the Donor. Clin J Am Soc Nephrol (2017) 0.75
Do we need a different organ allocation system for kidney transplants using donors after circulatory death? BMC Nephrol (2014) 0.75
Stretching the Limits of Renal Transplantation in Elderly Recipients of Grafts from Elderly Deceased Donors. J Am Soc Nephrol (2016) 0.75
High-pressure carbon monoxide preserves rat kidney grafts from apoptosis and inflammation. Lab Invest (2017) 0.75
Kidneys donated after cardiac death provide good graft survival and function up to 5 years. Nat Rev Nephrol (2010) 0.75
Kidneys donated after cardiac death are acceptable. Lancet (2010) 0.75
Kidney donation after cardiac death. World J Nephrol (2012) 0.75
Differing tales of two patients after receiving a kidney transplant from a donor with disseminated intravascular coagulation. Case Rep Transplant (2014) 0.75
Organ transplantation after cardiac death. Lancet (2011) 0.75
Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation. BMJ Open (2017) 0.75
Predicting patient survival after deceased donor kidney transplantation using flexible parametric modelling. BMC Nephrol (2016) 0.75
Kidney donation after circulatory death: current evidence and opportunities for pediatric recipients. Pediatr Nephrol (2015) 0.75
Posttransplant Outcomes of Kidneys Donated After Brain Death Followed by Circulatory Death: A Cohort Study of 128 Chinese Patients. Transplant Direct (2017) 0.75
Ischaemic and inflammatory injury in renal graft from brain death donation: an update review. J Anesth (2016) 0.75
Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet (2005) 3.73
Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study. Lancet (2012) 2.69
B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med (2009) 2.56
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
How insulin engages its primary binding site on the insulin receptor. Nature (2013) 2.52
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol (2005) 1.99
Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol (2005) 1.96
Gamma-aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. Anesthesiology (2008) 1.93
Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet (2012) 1.82
Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell (2012) 1.75
Evaluation of early abdominopelvic computed tomography in patients with acute abdominal pain of unknown cause: prospective randomised study. BMJ (2002) 1.69
Factors that influence access to the national renal transplant waiting list. Transplantation (2009) 1.65
TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J (2005) 1.60
A simplified donor risk index for predicting outcome after deceased donor kidney transplantation. Transplantation (2012) 1.57
Quality of life up to 30 years following liver transplantation. Liver Transpl (2008) 1.57
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology (2011) 1.51
Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation (2009) 1.49
Advising potential recipients on the use of organs from donors with primary central nervous system tumors. Transplantation (2012) 1.48
Cancer transmission from organ donors-unavoidable but low risk. Transplantation (2012) 1.46
High-throughput automated post-processing of separation data. J Chromatogr A (2004) 1.42
Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation. Transplantation (2010) 1.41
Equity of access to renal transplant waiting list and renal transplantation in Scotland: cohort study. BMJ (2003) 1.38
Transplantation between monozygotic twins: how identical are they? Transplantation (2014) 1.38
Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation (2007) 1.35
Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry. Transplantation (2014) 1.32
Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol (2010) 1.22
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years. Am J Transplant (2005) 1.22
TL1A both promotes and protects from renal inflammation and injury. J Am Soc Nephrol (2008) 1.18
Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci (2011) 1.17
Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation (2004) 1.16
Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol (2010) 1.15
The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15
Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant (2004) 1.14
Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells. J Immunol (2012) 1.08
Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation (2011) 1.07
Defining delayed graft function after renal transplantation: simplest is best. Transplantation (2013) 1.06
Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06
Factors affecting graft and patient survival after live donor kidney transplantation in the UK. Transplantation (2010) 1.04
The calcified abdominal cocoon. Lancet (2008) 1.04
In vivo neurochemical monitoring by microdialysis and capillary separations. Curr Opin Chem Biol (2002) 1.04
Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. Proc Natl Acad Sci U S A (2010) 1.03
Discovery and neurochemical screening of peptides in brain extracellular fluid by chemical analysis of in vivo microdialysis samples. Anal Chem (2004) 1.02
A comparison of three hard chairside denture reline materials. Part I. Clinical evaluation. Eur J Prosthodont Restor Dent (2003) 1.02
The discard of deceased donor kidneys in the UK. Clin Transplant (2014) 1.02
Allorecognition pathways in transplant rejection and tolerance. Transplantation (2013) 1.02
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl (2007) 1.02
Sirolimus-induced pneumonitis following liver transplantation. Liver Transpl (2007) 1.01
Renal transplantation in the United Kingdom for patients from ethnic minorities. Transplantation (2007) 1.01
Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation. Hum Immunol (2009) 1.00
Role of anti-vimentin antibodies in renal transplantation. Transplantation (2014) 1.00
Microdialysis coupled on-line to capillary liquid chromatography with tandem mass spectrometry for monitoring acetylcholine in vivo. J Neurosci Methods (2006) 1.00
The outcome of pediatric cadaveric renal transplantation in the UK and Eire. Pediatr Transplant (2002) 0.99
A New UK 2006 National Kidney Allocation Scheme for deceased heart-beating donor kidneys. Transplantation (2010) 0.98
Capillary liquid chromatography with MS3 for the determination of enkephalins in microdialysis samples from the striatum of anesthetized and freely-moving rats. J Mass Spectrom (2005) 0.98
Behavior-related alterations of striatal neurochemistry in a mouse model of stereotyped movement disorder. Pharmacol Biochem Behav (2004) 0.97
Summary of the British Transplantation Society/Renal Association U.K. guidelines for living donor kidney transplantation. Transplantation (2012) 0.97
Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation (2008) 0.97
Copresentation of intact and processed MHC alloantigen by recipient dendritic cells enables delivery of linked help to alloreactive CD8 T cells by indirect-pathway CD4 T cells. J Immunol (2013) 0.97
Is the increase in DCD organ donors in the United Kingdom contributing to a decline in DBD donors? Transplantation (2010) 0.97
Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation (2006) 0.96
Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants. Am J Pathol (2003) 0.96
Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Transplantation (2007) 0.95
Regulation of allograft survival by inhibitory FcγRIIb signaling. J Immunol (2012) 0.94
Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation (2011) 0.93
Structural integrity of the B24 site in human insulin is important for hormone functionality. J Biol Chem (2013) 0.91
Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J (2011) 0.91
Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Transplantation (2006) 0.91
Geographic disparities in access to organ transplantation in the United Kingdom. Transplantation (2003) 0.91
Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation. Transplantation (2006) 0.91
Early experience of paired living kidney donation in the United kingdom. Transplantation (2008) 0.90
Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies. Transplantation (2006) 0.90
Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation (2011) 0.90
Hypocretin and GABA interact in the pontine reticular formation to increase wakefulness. Sleep (2010) 0.89
Thermal nociception is decreased by hypocretin-1 and an adenosine A1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat. J Pain (2009) 0.89
Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection. Transplantation (2013) 0.89
Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Circ Heart Fail (2009) 0.88
Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity. J Immunol (2007) 0.88
OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation (2004) 0.88
Indirect allorecognition: not simple but effective. Transplantation (2008) 0.88
Multidisciplinary insights into optimizing adherence after solid organ transplantation. Transplantation (2010) 0.87
Filter-aided N-glycan separation (FANGS): a convenient sample preparation method for mass spectrometric N-glycan profiling. J Proteome Res (2014) 0.87
Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface. J Biol Chem (2011) 0.86
PECAM-1 polymorphism affects monocyte adhesion to endothelial cells. Transplantation (2008) 0.86
The UK scheme for mandatory continuous monitoring of early transplant outcome in all kidney transplant centers. Transplantation (2009) 0.85
Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation (2003) 0.85
A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation. Am J Transplant (2005) 0.85
Dendritic cells internalise and re-present conformationally intact soluble MHC class I alloantigen for generation of alloantibody. Eur J Immunol (2007) 0.85
Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation (2008) 0.85
High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol (2011) 0.85